%0
Generic
%T
Determinants of Treatment Benefit and Post-Treatment Survival for Patients with Hepatocellular Carcinoma Enrolled in Second-Line Trials after the Failure of Sorafenib Treatment
%A Personeni, Nicola
%A Pressiani, Tiziana
%A Zanuso, Valentina
%A Casadei-Gardini, Andrea
%A D’Alessio, Antonio
%A Valgiusti, Martina
%A Dadduzio, Vincenzo
%A Bergamo, Francesca
%A Soldà, Caterina
%A Rizzato, Mario Domenico
%A Giordano, Laura
%A Santoro, Armando
%A Rimassa, Lorenza
%I MDPI AG
%@ 2075-4426
%K Medicine (miscellaneous)
%D 2022
%C MDPI AG
%U http://slubdd.de/katalog?TN_libero_mab2